Bio Pharma Logistics Market - is Likely to Reach a Value of US$ 173.0 Bn by 2030, Future Scope, Size, Share | Marken, Air Canada Cargo, CEVA Logistics, Sofrigam

Market Overview:

Bio pharma logistics refers to specialized logistics services required for transporting temperature-controlled and other sensitive pharmaceutical products. It involves biomedical transport using various modes including transportation of vaccines, clinical drug products, medical equipment and other clinical supplies.

Market Dynamics:

The growth of the bio pharma logistics market is owing to increasing pharmaceutical sector investments towards R&D of novel drugs and vaccines and outsourcing of logistics operations by pharma manufacturers. The rising demand for fast-track deliveries and focus on delivery of products under proper temperature-controlled conditions is another driver bolstering the market growth. Furthermore, the increasing pharmaceutical e-commerce sector and growing need for innovative packaging solutions suitable for cross-border trade of pharmaceutical products fuels the bio pharma logistics industry expansion over the forecast period.

Get an Exclusive Sample Copy of the Report at: - https://www.coherentmarketinsights.com/insight/request-sample/6278

Driver: Increasing investment in R&D activities for developing new drugs and biologics

The bio pharma logistics market is witnessing growth in investments being made towards R&D activities related to developing new drugs and biologics for treating various chronic and complex diseases. The development of advanced medicines requires huge financial as well as resource investments from pharmaceutical companies. As new innovative drugs are being developed at a rapid pace to address the unmet medical needs of patients, the demand for specialized logistics services has also increased significantly. Bio pharma logistics providers play a crucial role in ensuring temperature-controlled transport and storage of clinical drug samples and medicines during various stages of drug development like clinical trials. They help maintain sample quality and safety by meeting stringent shipping and handling guidelines.

Rise in global trade of pharmaceutical products and clinical drug supplies

With the increasing globalization of drug production and rise in international partnerships and outsourcing activities between pharmaceutical manufacturers, the global trade of pharmaceutical products across borders has expanded rapidly in recent years. This has created a strong need for cross-border bio pharma logistics services. Pharmaceutical companies rely on third-party logistics providers to transport drugs, clinical supplies and materials between manufacturing sites, distribution centers and various end-users located across different countries and regions. International shipments require compliance with complex regulations of importing as well as exporting nations which presents new challenges for logistics players. However, it also opens up huge growth avenues as effective cross-border logistics remains a key enabler for the booming pharma trade worldwide.

Restrain: Lack of required logistics infrastructure in emerging markets

Emerging markets like Asia Pacific, Latin America, Middle East and Africa are witnessing high growth in pharma production and consumption. However, lack of specialized logistics infrastructure continues to hamper the supply chain capabilities in these regions. Absence of temperature-controlled warehousing, insufficient cold chain networks and limited intermodal facilities challenge the smooth and compliant transport of pharmaceuticals. Pharma logistics providers face difficulties in expanding their reach to remote and underdeveloped areas due to infrastructure gaps. Addressing infrastructure shortcomings requires large investments from governments as well as private players. Until infrastructural barriers are overcome, the bio pharma logistics potential in emerging markets may not be fully realized.

Opportunity: Increased demand for cold chain logistics with growth of biopharma industry

The global biopharmaceutical industry has registered strong growth over the past decade led by biologics and biosimilars. Biologics are temperature-sensitive and require specialized cold chain logistics right from the manufacturing site to the patient. As biologics dominate the current pharma pipeline and marketing approvals, their commercialization is driving exponential rise in demand for temperature-controlled logistics across the supply chain. Cold storage warehouses, refrigerated trucks, passive & active packaging solutions and continuous temperature monitoring systems are some of the key technologies seeing increased investments. Bio pharma logistics providers are enhancing their service capabilities to effectively manage the complex cold chain requirements for transporting biologic drugs. This presents a huge opportunity for growth and expansion in the years ahead.

Buy This Premium Report and Get Upto 25 % OFF: https://www.coherentmarketinsights.com/insight/buy-now/6278

Trend: Adoption of digitized solutions for supply chain visibility and real-time monitoring

Pharmaceutical logistics networks are becoming increasingly complex with globalization of drug production and rise of temperature-sensitive biologics. Ensuring product quality, compliance and on-time deliveries in such dynamic supply chains requires maximum visibility. Therefore, logistics providers are intensifying adoption of various digitized tools like wireless sensors, blockchain, Internet of Things (IoT), cloud computing and analytics. These technologies help achieve end-to-end supply chain visibility and real-time monitoring of critical parameters like location, temperature, humidity during transit. They generate vast amounts of data that can be analyzed for process optimization, predictive maintenance, quality assurance and troubleshooting. Integration of advanced technologies will thus remain a prominent trend shaping the future of the bio pharma logistics domain.

Moreover, it will also include the opportunities available in micro markets for stakeholders to invest, a detailed analysis of the competitive landscape, and product services of key players. Analysis of Bio Pharma Logistics companies, key tactics followed by Leading Key Players:

◘ DHL
◘ FedEx
◘ UPS
◘ DB Schenker
◘ Kuehne + Nagel
◘ SF Express
◘ Kerry Logistics
◘ Agility Logistics
◘ VersaCold Logistics Services
◘ Marken
◘ Air Canada Cargo
◘ CEVA Logistics
◘ Sofrigam
◘ Nordic Cold Storage
◘ Biocair
◘ United Parcel Service
◘ Cavalier Logistics
◘ LifeConEx
◘ AirBridgeCargo Airlines
◘ World Courier

Note: Major Players are sorted in no particular order.

By Type

Cold Chain Logistics
Non-cold Chain Logistics

By Service Type

Transportation
Warehousing
Packaging
Others

By Application

Biologics
Prescribed drugs
Over-the-Counter medicines
Raw materials and bulk pharmaceuticals
Others

The Study Objectives are:

A comprehensive insight into key players operating in the Bio Pharma Logistics Market and their corresponding data.
It includes product portfolio, annual revenue, expenditure on research and development, geographical presence, key developments in recent years, and growth strategies.
Regional analysis, which includes insight into the dominant market and corresponding market share.
It also includes various socio-economic factors affecting the evolution of the market in the region.
The report offers a comprehensive insight into different individuals from value chains such as raw materials suppliers, distributors, and stockholders.
Table of Contents:

Market scenario 2023

Chapter 1: Introduction, Market Driving Force Product Objective of Study and Research Scope the Bio Pharma Logistics market
Chapter 2: Exclusive Summary - the basic information of the Bio Pharma Logistics Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends, and Challenges & Opportunities of the Bio Pharma Logistics
Chapter 4: Presenting the Bio Pharma Logistics Market Factor Analysis, Supply/Value Chain, PESTEL analysis, Market Entry, and Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User, and Region/Country 2023 - 2030
Chapter 6: Evaluating the leading manufacturers of the Bio Pharma Logistics market which consists of its Competitive Landscape, Peer Group Analysis, Market positioning & Company Profile
Chapter 7: To evaluate the market by segments, by countries, and by Manufacturers/Companies with revenue share and sales by key countries in these various regions (2023-2030)
Chapters 8 & 9: Displaying the Appendix, Methodology, and Data Source

We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/6278

Key Questions Answered:

What is the market size and CAGR of the Bio Pharma Logistics Market during the forecast period?
How is the growing demand impacting the growth of Bio Pharma Logistics Market shares?
What is the growing demand of the Market during the forecast period?
Who are the leading vendors in the market and what are their market shares?
What is the impact of the COVID-19 pandemic on the APAC Bio Pharma Logistics Market?

Contact Us

Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
JAPAN:+81-50-5539-1737
INDIA:+91-848-285-0837
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.